通心络胶囊治疗冠心病稳定性心绞痛效果分析

Effect of Tongxinluo capsule on stable angina pectoris induced by coronary heart disease

目的探究冠心病稳定性心绞痛患者接受通心络胶囊治疗的效果。方法以冠心病稳定性心绞痛患者为研究对象,时间选取为2016年3月—2018年3月,例数为100例,通过随机数字表法分组,其中对照组实施硝酸酯类、β受体阻断剂、阿司匹林等常规治疗,实验组则同时接受通心络胶囊治疗,分析两组冠心病稳定性心绞痛患者治疗的效果。结果实验组冠心病稳定性心绞痛患者心绞痛改善的总有效率(92.00%)明显较对照组总有效率(74.00%)高(P<0.05);实验组心电图总有效率(72.00%)明显较对照组总有效率(44.00%)高,差异有统计学意义(P<0.05);两组不良反应发生率相比,无统计学意义(P>0.05)。结论冠心病稳定性心绞痛患者接受通心络胶囊治疗,具有较高的安全性和有效性。

Objective To explore the effect of Tongxinluo capsule on patients with stable angina pectoris.Methods A total of 100 patients with stable angina pectoris of coronary heart disease from March 2016 to March2018 were randomly divided into two groups.The control group was given routine treatment such as nitrates,betablockers and aspirin,while the experimental group was given Tongxinluo capsule. The outcomes of treatment for stable angina pectoris of the two groups were compared. Results The total effective rate( 92. 00%) of angina pectoris in the experimental group was significantly higher than that in the control group( 74.00%) and the total effective rate( 72.00%) of ECG in the experimental group was significantly higher than that in the control group( 44.00%).The differences were statistically significant( P<0.05).There was no significant in the occurrence of adverse effects between the two groups( P> 0.05). Conclusions Tongxinluo capsule is safe and effective in the treatment of patients with stable angina pectoris of coronary heart disease.